QS PHARMA Trademark

Trademark Overview


On Wednesday, October 2, 2002, a trademark application was filed for QS PHARMA with the United States Patent and Trademark Office. The USPTO has given the QS PHARMA trademark a serial number of 76454803. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Tuesday, June 29, 2004. This trademark is owned by QS Pharma LLC. The QS PHARMA trademark is filed in the Pharmaceutical Products, Advertising and Business and Retail Services categories with the following description:

Pharmaceutical preparations for the prevention, mitigation, and treatment of cancer, cardiovascular diseases, central nervous system diseases, gastrointestinal diseases, infections, metabolic diseases, musculoskeletal diseases, obesity, respiratory diseases, thromboembolic diseases, and urogenital diseases

providing outsourcing services for pharmaceutical and other companies relating to the development of compounds and determining the viability and usefulness of compounds for medical and other applications
qs pharma

General Information


Serial Number76454803
Word MarkQS PHARMA
Filing DateWednesday, October 2, 2002
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateTuesday, June 29, 2004
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 18, 2003

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention, mitigation, and treatment of cancer, cardiovascular diseases, central nervous system diseases, gastrointestinal diseases, infections, metabolic diseases, musculoskeletal diseases, obesity, respiratory diseases, thromboembolic diseases, and urogenital diseases
Goods and Servicesproviding outsourcing services for pharmaceutical and other companies relating to the development of compounds and determining the viability and usefulness of compounds for medical and other applications
Pseudo MarkQS PHARMA

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateTuesday, June 29, 2004
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code8 - Abandoned
Class Status DateTuesday, June 29, 2004
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameQS Pharma LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19810

Party NameQS Pharma LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19810

Trademark Events


Event DateEvent Description
Tuesday, June 29, 2004ABANDONMENT - AFTER INTER PARTES DECISION
Tuesday, June 29, 2004OPPOSITION TERMINATED NO. 999999
Tuesday, June 29, 2004OPPOSITION TERMINATED NO. 999999
Friday, June 18, 2004OPPOSITION TERMINATED NO. 999999
Friday, June 18, 2004OPPOSITION TERMINATED NO. 999999
Friday, June 18, 2004OPPOSITION DISMISSED NO. 999999
Wednesday, June 2, 2004PAPER RECEIVED
Tuesday, March 23, 2004OPPOSITION INSTITUTED NO. 999999
Saturday, December 13, 2003EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, November 18, 2003PUBLISHED FOR OPPOSITION
Wednesday, October 29, 2003NOTICE OF PUBLICATION
Wednesday, September 10, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 11, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 29, 2003CASE FILE IN TICRS
Monday, August 11, 2003PAPER RECEIVED
Monday, February 10, 2003NON-FINAL ACTION MAILED
Friday, January 31, 2003ASSIGNED TO EXAMINER